Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin
Journal of the Pakistan Medical Association · 20.04.2026 · 76 (05) · 662-666
DOI: 10.47391/jpma.22072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 20.04.2026. Verfasst von Muhammad Usman Shams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology and Lab Management, University of Health Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Skin Neoplasms, Cutaneous Squamous Cell Carcinoma, Carcinoma, Squamous Cell. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess the frequency and level of expression of enhancer of zeste homologue 2 in cutaneous squamous cell carcinoma, and compare then with normal skin.
Method
The retrospective, descriptive study was conducted at the Department of Morbid Anatomy and Histopathology, University of Health Sciences, Lahore, Pakistan, and comprised data from January 2016 to April 2023 related to cutaneous squamous cell carcinoma in group A and normal skin cases in group B that were evaluated and compared for enhancer of zeste homologue 2 immunohistochemistry expression and positivity. Group A cases with increased immunohistochemistry expression were tested by fluorescence in situ hybridisation for enhancer of zeste homologue 2 amplification. Data was analysed using SPSS 22.
Results
Of the 60 patients, 30(50%) were in group A; 19(63.3%) males and 11(36.7%) females with mean age 48±16.5 years. There were 30(50%) patients in group B; 29(96.7%) females and 1(0.3%) male with mean age 47.6±11.3 years. There were 25(83.3%) well-differentiated cases in group A. Enhancer of zeste homologue 2 positivity was noted in 25(83.3%) case in group A compared to 6(20%) in group B (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histopathology and Lab Management, University of Health Sciences, Lahore, Pakistan.
- University of Health Sciences, Lahore, Pakistan.
Zitieren
APA
Shams, M. U., Nagi, A. H., Mehmood, S., & Henna, N. (2026). Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin. Journal of the Pakistan Medical Association, 76(05), 662-666. https://doi.org/10.47391/jpma.22072
Vancouver
Shams MU, Nagi AH, Mehmood S, Henna N. Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin. Journal of the Pakistan Medical Association. 2026;76(05):662-666. doi:10.47391/jpma.22072
BibTeX
@article{Shams2026,
author = {Shams, Muhammad Usman and Nagi, Abdul Hannan and Mehmood, Saqib and Henna, Nausheen},
title = {Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin},
journal = {Journal of the Pakistan Medical Association},
year = {2026},
volume = {76},
number = {05},
pages = {662--666},
doi = {10.47391/jpma.22072}
}
EUVIMED